NEW YORK, Sept. 14, 2010 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease (AD), with an internal diversified pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, unveiled its new website on September 10, 2010. The site, www.Intellectns.com, incorporates numerous features to make browsing a more efficient experience for the Company's current and potential partners and investors.
